M Merger - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Gut|July 16, 2002

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestineM Merger, J L Viney, R Borojevic, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001

Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activitiesP D Smith, L E Smythies, M Mosteller-Barnum, et al.

Gynecologic Oncology|November 24, 2018

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Gut|July 16, 2002

Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestineM Merger, J L Viney, R Borojevic, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001

Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activitiesP D Smith, L E Smythies, M Mosteller-Barnum, et al.

Gynecologic Oncology|November 24, 2018

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.

Pageof 2